2026 NPPES data Hematology & Oncology Physician NPI 1114131711 MD
Verify on CMS →

MARK PAJEAU, MD

Hematology & Oncology Physician in ROLLA, Missouri. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
4K
Medicare Part D claims · 492 beneficiaries · Hematology & Oncology Physician avg: 847
MIPS score
8.3018/100
▼ 75 pts below national avg 83.1 · [object Object]
Industry payments
$273.55
13 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: MARK PAJEAU, MD is a Hematology & Oncology Physician ([object Object]) practicing in ROLLA, Missouri with a Medicare Part D prescribing footprint of 4K claims across 492 beneficiaries . Their CMS MIPS Final Score of 8.3018/100 (national average: 83.1) reflects performance across Quality, Cost, Interoperability, and Improvement Activities . Industry payments of $273.55 across 13 transactions are disclosed under CMS Open Payments (Sunshine Act).

What stands out: MARK PAJEAU, MD reported a CMS MIPS final score of 8.3018 out of 100, below the 83.1 national average, and filed 3,687 Medicare Part D claims in 2023. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

Board certification likely (heuristic — not verified)

MARK PAJEAU, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

MARK PAJEAU, MD at a glance

Below national average

NPI registry status

Active

Issued 05/10/2007

NPI 1114131711

Primary specialty

Hematology & Oncology Physician

Mid-sized

11,215 US NPIs in this specialty

Medicare Part D claims

3,687 335% vs specialty avg

2023 prescription claims

Specialty avg: 847

MIPS final score

8.3018/100 74.7982% pts

Penalty band band

vs 83.1 national avg

Specialty distribution in Missouri

How Hematology & Oncology Physician compares to other specialties among Missouri providers

Missouri providers

Hematology & Oncology Physician share within Missouri

1. Hematology & Oncology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Hematology & Oncology Physician share within Missouri

Medicare quality performance — MIPS

MARK PAJEAU, MD's 2023 MIPS final score plotted against the Hematology & Oncology Physician national average

Below national average
MIPS Final Score
8.3018/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Hematology & Oncology Physician) — 8.3018/100 vs national avg 83.1

0%100%National avg83%8.3%
MIPS final score (Hematology & Oncology Physician) — 8.3018/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

MARK PAJEAU, MD is a Hematology & Oncology Physician provider practicing in ROLLA, Missouri, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: MD. NPI: 1114131711. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

MARK PAJEAU, MD appears in the CMS NPPES registry as a Hematology & Oncology Physician provider holding MD credentials at 1060 W 10TH ST, ROLLA, MO, 65401, with a listed phone of (855) 406-3324. NPI 1114131711 was issued on 05/10/2007. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what PAJEAU most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 3,687 prescription claims written by this provider, covering 492 Medicare beneficiaries and totaling roughly $2.0 million in drug spend, with an opioid prescribing rate of 14.6%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 8.3018/100 for the 2023 performance year (Quality 0, Cost 27.6726), compared with the national average of 83.1.

Hematology & Oncology Physician is a mid-sized specialty nationwide, with 11,215 enrolled providers across 54 states and an average of 847 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

1060 W 10TH ST
ROLLA, MO 65401

Provider Details

NPI 1114131711
Specialty Hematology & Oncology Physician
Credentials MD
Gender Male
NPI Issued 05/10/2007

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

8.3018
Final Score
Avg: 83.1
0
Quality
27.6726
Cost
0
Promoting Interoperability

Reporting: Individual

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for MARK PAJEAU, MD. Source: openpaymentsdata.cms.gov.

Total received

$274

Largest payer

Novartis Pharmaceuticals Corporation

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

3,687
Total Claims
$2.0M
Total Drug Cost
492
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
4,983
Total Day Supply
135,993
Generic Drug Cost
$288K
Opioid Claims
539 (14.6% rate)
Antibiotic Claims
213

Patient Demographics

Average Patient Age
72.0 years
Avg HCC Risk Score
2.14
Gender Split
62% female / 38% male
Age Distribution
<65: 85, 65-74: 212, 75-84: 133, 85+: 62

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Prednisone
203
Hydrocodone-Acetaminophen
Hydrocodone/Acetaminophen
197
Oxycodone Hcl
183
Letrozole
182
Eliquis
Apixaban
155
Alprazolam
146
Gabapentin
91
Anastrozole
74
Methylphenidate Hcl
73
Ondansetron Hcl
73

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Hematology & Oncology Physician Overview

How MARK PAJEAU, MD fits within the Hematology & Oncology Physician landscape nationally.

11,215
Hematology & Oncology Physician Providers in US
54
States with Hematology & Oncology Physician
847
Avg Claims per Provider

MARK PAJEAU, MD's 3,687 claims are above the specialty average of 847.

Nearby Hematology & Oncology Physician Providers in Missouri

Other clinicians with the same primary specialty enrolled in Missouri, drawn from the same CMS NPPES roster as PAJEAU.

Compare Hematology & Oncology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is MARK PAJEAU, MD's specialty?
MARK PAJEAU, MD specializes in Hematology & Oncology Physician and practices in ROLLA, Missouri. Credentials: MD.
How much does MARK PAJEAU, MD prescribe under Medicare Part D?
In 2023, MARK PAJEAU, MD wrote 3,687 Medicare Part D claims totaling $2.0M in drug costs for 492 beneficiaries.
What is MARK PAJEAU, MD's Medicare quality score?
MARK PAJEAU, MD has a CMS MIPS Final Score of 8.3018/100 (Quality: 0, Cost: 27.6726). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is MARK PAJEAU, MD located?
MARK PAJEAU, MD is located at 1060 W 10TH ST, ROLLA, MO, 65401. Phone: (855) 406-3324.
What is MARK PAJEAU, MD's NPI number?
MARK PAJEAU, MD's National Provider Identifier (NPI) is 1114131711, issued on 05/10/2007.
Does MARK PAJEAU, MD prescribe opioids?
Yes, MARK PAJEAU, MD had 539 opioid claims in 2023 with an opioid prescribing rate of 14.6%.
How many Hematology & Oncology Physician providers are there in the US?
There are 11,215 Hematology & Oncology Physician providers across 54 states in the US. The average Hematology & Oncology Physician provider writes 847 Medicare Part D claims per year.
What drugs does MARK PAJEAU, MD prescribe most often?
Based on 2023 Medicare Part D data, MARK PAJEAU, MD's most frequently prescribed drugs include Prednisone, Hydrocodone-Acetaminophen, Oxycodone Hcl. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does MARK PAJEAU, MD accept Medicare?
MARK PAJEAU, MD appears in CMS Medicare data with 3,687 Part D claims and 492 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify MARK PAJEAU, MD's credentials?
MARK PAJEAU, MD's NPI is 1114131711 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology